公司概覽
業務類別 Drug Manufacturers - Specialty & Generic
業務概覽 Incannex Healthcare Inc is a clinical-stage biopharmaceutical development company dedicated to developing inventive medicines for patients living with serious chronic diseases and unmet needs. The Company's drug candidates include IHL-42X for the treatment of obstructive sleep apnea (OSA) and PSX-001, the Company's psilocybin treatment in combination with psychological therapy in development to treat patients with generalized anxiety disorder (GAD). The Company also has a drug candidate, IHL-675A, for the treatment of rheumatoid arthritis. Each of these programs target conditions that currently have limited, inadequate, or no approved pharmaceutical treatment options. The Company continues to evaluate strategies for IHL-675A when and as resources permit.
公司地址 525 Collins Street, Rialto South Tower Level 23, Melbourne, VIC, AUS, 3008
電話號碼 +61 409840786
傳真號碼 +61 425703805
公司網頁 https://www.incannex.com.au
員工數量 12
 
公司高管 / 董事會成員
公司高管
高管 職務 年薪 更新日期
Mr. Lekhram Changoer Chief Technology Officer -- 28/10/2026
Mr. Joel Latham Director, Chief Executive Officer and President 美元 790.00K 28/10/2026
Mr. Joseph Swan Principal Accounting Officer, Chief Financial Officer and Secretary 美元 198.26K 28/10/2026
Dr. Luigi M. Barbato, M.D. Chief Medical Officer 美元 375.00K 28/10/2026
 
董事會成員
董事會 職務 更新日期
Dr. George E. Anastassov, M.D. Independent Director 28/10/2026
Mr. Joel Latham Director, Chief Executive Officer and President 28/10/2026
Mr. Troy Valentine Chairman of the Board 28/10/2026
Mr. Peter Widdows Independent Director 28/10/2026
Mr. Robert Clark Independent Director 28/10/2026
 
所屬ETF (更新日期: 07/11/2026 04:32)
代號 名稱 佔比% ▼ 持有日期
PSILAdvisorShares Psychedelics ETF1.25%30/10/2026
 

Copyright © 2026 ET Net Limited.
All rights reserved. Use of this site signifies your agreement to the terms of use.
DISCLAIMER: ET Net Limited and Third Party Information Providers endeavour to ensure the accuracy and reliability of the information provided, but do not guarantee its accuracy and reliability and accept no liability (whether in tort or contract or otherwise) for any loss or damage arising from any inaccuracies or omissions.